You are here
REPLIGEN CORPORATION
UEI: N/A
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
IMPROVED SECRETIN ANALOGS FOR THE TREATMENT OF AUTISM
Amount: $100,000.00Non invasive MRI evaluation of the carotid artery wall lumen and blood flow patterns is hampered by the lack of a comprehensive and anatomically correct commercially available flow phantom. The objec ...
SBIRPhase I2002Department of Health and Human Services National Institutes of Health -
Development of a Heparinoid Affinity Matrix by Combinatorial Chemistry
Amount: $99,906.00N/A
SBIRPhase I1999National Science Foundation -
HEPARANASE INHIBITORS FOR USE IN METASTATIC DISEASES
Amount: $99,660.00Not Available Oman Moments, Inc. will conduct a Phase 1 trade study to determine the best approach for providing both day and night imaging of ground targets from a supersonic missile. The objective ...
SBIRPhase I1999Department of Health and Human Services -
Development of Chemokines for Myeloprotection
Amount: $749,999.00We will develop a myelostatic agent to protect human hematopoietic precursor cells from the destrucchemotherapeutic agents currently used in the treatment of tumors. We propose that protection of prei ...
SBIRPhase II1998Department of Health and Human Services -
Development of Chemokines for Myeloprotection
Amount: $99,998.00We will develop a myelostatic agent to protect human hematopoietic precursor cells from the destrucchemotherapeutic agents currently used in the treatment of tumors. We propose that protection of prei ...
SBIRPhase I1995Department of Health and Human Services -
GENERATION OF PF4 POLYETHYLENE GLYCOL CONJUGATES
Amount: $27,274.00ANGIOGENESIS IS A COMPLEX PROCESS INVOLVING THE PROLIFERATION, MIGRATION, AND PRECISE THREE DIMENSIONAL ALIGNMENT OF ENDOTHELIAL CELLS. A WIDE RANGE OF DISEASE PROCESSES INCLUDING SOLID TUMOR GROWTH, ...
SBIRPhase I1991Department of Health and Human Services -
ANTIBODY HETEROCONJUGATES FOR TREATMENT OF SIV INFECTION
Amount: $49,984.00THE GOAL OF THIS PROJECT IS TO GENERATE AND CHARACTERIZE A BISPECIFIC HETEROCONJUGATE ANTIBODY CAPABLE OF INDUCING THE CYTOLYSIS OF SIV-INFECTED CELLS. THE APPROACH IN PHASE I STUDY WILL ENTAIL CONJUG ...
SBIRPhase I1991Department of Health and Human Services -
SUPPOSITORIES FOR RAPID ANTI-EPILEPTIC DIAZEPAM DELIVERY
Amount: $49,861.00N/A
SBIRPhase I1991Department of Health and Human Services -
LIGNINOLYTIC ENZYMES APPLIED TO KRAFT LIGNIN AND LIGNOSULFONATE UTILIZATION
Amount: $479,000.00LIGNIN, A COMPLEX ORGANIC POLYMER AND ONE OF THE EARTH'S MOST ABUNDANT MOLECULES, IS NOW A LOW-VALUE BY-PRODUCT OF WOOD PULP PROCESSING. THE MAJOR LIGNIN BY-PRODUCTS, KRAFT LIGNIN, AND LIGNOSULFONATES ...
SBIRPhase II1986Department of Energy -
LIGNINOLYTIC ENZYMES APPLIED TO KRAFT LIGNIN AND LIGNOSULFONATE UTILIZATION
Amount: $50,000.00N/A
SBIRPhase I1985Department of Energy
